Bioalternatives is a contract research organization (CRO) specializing in cellular and molecular pharmacology. It was founded in 1996 by Dr. François-Xavier BERNARD and Dr. Alain DEGUERCY.

Our laboratory is committed to developing effective in vitro alternative options to animal experimentation methods, by offering a full range of solutions for preclinical research and for the development of drug candidates or of active ingredients and cosmetic formulations.

Beyond this historical product evaluation and optimization activity, Bioalternative assists the health industry in its new strategic choices by offering competitive custom-oriented and collaborative innovation services.

KEY FIGURES

1000

square meter laboratory

46

employees
(30 scientists)

500 +

in vitro and ex vivo assays in our catalog

15 % +

R&D investments

300 +

studies / year

BACKGROUND

OUR LOCATIONS

Bioalternatives, Inc.

90 Park Avenue,
17 th Floor
New York, NY 10016
USA

+1 (212) 364 5115

Bioalternatives SAS

1 bis rue des plante
BP 50011
86160 Gençay
FRANCE

+33 (0)5 49 36 11 37

Toyo Science Corp

Bldg. 1-21 Nihonbashi,
Muromachi 4-chrome
Chuo-ku, Tokyo 103-0022
JAPAN

+81 (0)3 5205 1040

www.toyo-asia.co.jp